Meridian Bioscience Reports 7 Percent Spike in Fiscal Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 7 percent year-over-year uptick in fiscal first quarter revenues driven by balanced contributions from its key operating segments.

For the three months ended Dec. 31, the Cincinnati-based molecular diagnostics and life science research tools firm brought in revenue of $48 million compared to $44.8 million in the same quarter last year and beating the consensus analysts' estimate of $46.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.